News Sentiment

VRTX sentiment intelligence

Vertex Pharmaceuticals Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 55 Balanced news tone 30 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8319.00 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

89/100 classification confidence.

Company focus 30

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-2.5% over one week, +6.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 89/100 classification
One-week reaction -2.5% Price reacting lower
Trend fit Trend inactive 6.7% over four weeks
Fair value 3.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 17
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 30
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
simplywall.st 2
MSN 2
Trefis 2
ChartMill 1
AOL.com 1
Bloomberg.com 1
Reuters 1

Event Lens

What the news is about

Classified themes
Market update 25
Deals and strategy 4
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 30